Results 61 to 70 of about 1,065,378 (291)
The thermal stability of yellow fever vaccines
Memorias do Instituto Oswaldo Cruz, 1990 The assessment of yellow fever vaccine thermostability both in lyophilized form and after reconstitution were analyzed. Two commercial yellow fever vaccines were assayed for their thermal stability. Vaccines were exposed to test temperatures in the range
Ricardo Ishak, Colin R. Howard
doaj +1 more source
Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009. [PDF]
PLoS Neglected Tropical Diseases, 2014 Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease.
Alessandro Pecego Martins Romano +8 more
doaj +1 more source
Re-emergence of yellow fever in the neotropics — quo vadis?
Emerging Topics in Life Sciences, 2020 Yellow fever virus (YFV) is the etiological agent of yellow fever (YF), an acute hemorrhagic vector-borne disease with a significant impact on public health, is endemic across tropical regions in Africa and South America.
L. Sacchetto +4 more
semanticscholar +1 more source
Anamnestic immune response to dengue and decreased severity of yellow fever
Journal of Global Infectious Diseases, 2009 A protective immunity against yellow fever, from cross-reactive dengue antibodies, has been hypothesized as an explanation for the absence of yellow fever in Southern Asia where dengue immunity is almost universal.
Ricardo O Izurieta +7 more
doaj +1 more source
Yellow fever – An old foe with new developments [PDF]
Introduction: Yellow fever is caused by an RNA flavivirus. Immunisation in conjunction with vector control is at the forefront of yellow fever control and elimination.
Grahn, Emily +2 more
core +1 more source
Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis. [PDF]
, 2017 BACKGROUND: Substantial outbreaks of yellow fever in Angola and Brazil in the past 2 years, combined with global shortages in vaccine stockpiles, highlight a pressing need to assess present control strategies.
Brady, Oliver J +19 more
core +3 more sources
Proceedings of the National Academy of Sciences of the United States of America, 2020 Significance Fatal cases of yellow fever are preceded by the development of hemorrhagic complications. While yellow fever virus is known to infect hepatocytes, the relationship between hepatocyte infection and the development of hemorrhage is currently ...
Adam Leitman Bailey +14 more
semanticscholar +1 more source
Genomic and epidemiological monitoring of yellow fever virus transmission potential
Science, 2018 Arbovirus risk in Brazil Despite the existence of an effective vaccine for yellow fever, there are still almost 80,000 fatalities from this infection each year.
N. Faria +87 more
semanticscholar +1 more source
Yellow Fever in Nigeria: A Review of Past, Current, and Future Strides
The Proceedings of the Nigerian Academy of Science, 2022 Since 1985, there has been resurgence of yellow fever in Africa with outbreaks occurring in more than 33 countries. From that time, thousands of cases have occurred in Nigeria which is the most populous country in Africa.
Anyebe B. Onoja +5 more
doaj +1 more source
Inferring the immune response from repertoire sequencing [PDF]
PLoS Comput Biol 16(4): e1007873 (2020), 2019 High-throughput sequencing of B- and T-cell receptors makes it possible to track immune repertoires across time, in different tissues, and in acute and chronic diseases or in healthy individuals. However, quantitative comparison between repertoires is confounded by variability in the read count of each receptor clonotype due to sampling, library ...
arxiv +1 more source